Could adding oxytocin speed up labor induction after a C-Section?
NCT ID NCT07006896
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to start labor in women who have had one previous C-section and are at least 37 weeks pregnant with a single baby. One method uses a cervical balloon alone, and the other uses the balloon along with the drug oxytocin. The goal is to see if using both together can shorten the time from start to delivery without raising risks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Foley balloon and oxytocin
What this could lead to
If successful, this could establish a safer, faster method for inducing labor in women with a prior C-section, reducing time to delivery without increasing risks.
What could go wrong
This is a small, early-stage trial with only 100 participants, so results may not apply broadly. Adding oxytocin could raise the risk of uterine rupture or other complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN DELIVERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19146, United States